Cargando…

Clinicopathological significance of ZEB-1 and E-cadherin proteins in patients with oral cavity squamous cell carcinoma

BACKGROUND: Zinc-finger E-box binding homeobox 1 (ZEB-1), a member of the ZFH family, plays a key role in epithelial–mesenchymal transition during tumor progression in various cancers. However, little information is available on ZEB-1 expression in oral cavity squamous cell carcinoma (OSCC). METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Xiaofeng, Sun, Shanshan, Zhou, Xuan, Zhang, Qiang, Guo, Wenyu, Zhang, Lun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315354/ https://www.ncbi.nlm.nih.gov/pubmed/28243114 http://dx.doi.org/10.2147/OTT.S111920

Ejemplares similares

Cadherin switching in oral squamous cell carcinoma: A clinicopathological study
por: Ali, Ahmed Noaman, et al.
Publicado: (2023)

Prognostic significance of E-cadherin and ZEB1 expression in intraductal papillary mucinous neoplasm
por: Chang, Ye Rim, et al.
Publicado: (2017)

Role of epithelial-mesenchymal transition markers E-cadherin, N-cadherin, β-catenin and ZEB2 in laryngeal squamous cell carcinoma
por: Zhu, Guang-Jie, et al.
Publicado: (2018)

Thyroid hormone induces progression and invasiveness of squamous cell carcinomas by promoting a ZEB-1/E-cadherin switch
por: Miro, Caterina, et al.
Publicado: (2019)

Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC)
por: Hashiguchi, Motoyuki, et al.
Publicado: (2013)

Expression of E-cadherin and β-catenin in basaloid and conventional squamous cell carcinoma of the oral cavity: are potential prognostic markers?
por: Hanemann, João Adolfo Costa, et al.
Publicado: (2014)

Progression of Oral Squamous Cell Carcinoma Accompanied with Reduced E-Cadherin Expression but Not Cadherin Switch
por: Hashimoto, Takashi, et al.
Publicado: (2012)

Author Correction: Thyroid hormone induces progression and invasiveness of squamous cell carcinomas by promoting a ZEB-1/E-cadherin switch
por: Miro, Caterina, et al.
Publicado: (2020)

Clinicopathological significance and potential drug target of T-cadherin in NSCLC
por: Wang, Zhidong, et al.
Publicado: (2014)

Clinicopathological significance of E-cadherin, β-catenin and p53 expression in gastric adenocarinoma
por: Zali, Mohammad Reza, et al.
Publicado: (2009)

Prognostic and Clinicopathological Significance of E-Cadherin in Pancreatic Cancer Patients: A Meta-Analysis
por: Wang, Pengbo, et al.
Publicado: (2021)

Prognostic Role of Epithelial-Mesenchymal Transition Markers “E-Cadherin, β-Catenin, ZEB1, ZEB2 and p63” in Bladder Carcinoma
por: Moussa, Rabab Ahmed, et al.
Publicado: (2019)

Clinicopathological Significance of the ET Axis in Human Oral Squamous Cell Carcinoma
por: Miyazawa, Hiroki, et al.
Publicado: (2018)

Clinicopathological and Prognostic Significance of Stromal Patterns in Oral Squamous Cell Carcinoma
por: Amano, Yusuke, et al.
Publicado: (2022)

Significance of Twist expression and its association with E-cadherin in esophageal squamous cell carcinoma
por: Sasaki, Ken, et al.
Publicado: (2009)

Immunohistochemical Expression of E-Cadherin and β-Catenin in Oral Squamous Cell Carcinoma
por: Akinyamoju, Akindayo Olufunto, et al.
Publicado: (2023)

PTTG1/ZEB1 Axis Regulates E-Cadherin Expression in Human Seminoma
por: Teveroni, Emanuela, et al.
Publicado: (2022)

E-cadherin Expression in Canine Gastric Carcinomas: Association with Clinicopathological Parameters
por: Flores, Ana R., et al.
Publicado: (2022)

The prognostic significance of E-cadherin expression in laryngeal squamous-cell carcinoma: a systematic review
por: RE, M., et al.
Publicado: (2018)

Clinicopathological and Prognostic Significance of Survivin Expression in Patients with Oral Squamous Cell Carcinoma: Evidence from a Meta-Analysis
por: Xie, Shang, et al.
Publicado: (2015)

Expression and clinical implication of cyclooxygenase-2 and E-cadherin in oral squamous cell carcinomas
por: Santoro, Angela, et al.
Publicado: (2020)

Correlation of E-cadherin Immunohistochemical Expression with Histopathological Grading of Oral Squamous Cell Carcinoma
por: Kushwaha, Sandhya Singh, et al.
Publicado: (2019)

NAC1 Regulates Somatic Cell Reprogramming by Controlling Zeb1 and E-cadherin Expression
por: Faiola, Francesco, et al.
Publicado: (2017)

The Expression and Functional Significance of Vascular Endothelial-Cadherin, CD44, and Vimentin in Oral Squamous Cell Carcinoma
por: Irani, Soussan, et al.
Publicado: (2018)

Prognostic significance of E-cadherin and N-cadherin expression in Gliomas
por: Noh, Myung-Giun, et al.
Publicado: (2017)

Clinicopathological Significance of AKT1 and PLK1 Expression in Oral Squamous Cell Carcinoma
por: Sun, Er-Can, et al.
Publicado: (2022)

Down regulation of E-Cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx
por: Huber, Gerhard F, et al.
Publicado: (2011)

Association of E-cadherin & vimentin expression with clinicopathological parameters in lingual squamous cell carcinomas & their role in incomplete epithelial mesenchymal transition
por: Goyal, Neelakshi, et al.
Publicado: (2021)

Evaluation of Lymphatic and Vascular Invasion in Relation to Clinicopathological Factors and Treatment Outcome in Oral Cavity Squamous Cell Carcinoma
por: Adel, Mohamad, et al.
Publicado: (2015)

Clinical Significance in Oral Cavity Squamous Cell Carcinoma of Pathogenic Somatic Mitochondrial Mutations
por: Lai, Chih-Hsiung, et al.
Publicado: (2013)

ZEB1 and oncogenic Ras constitute a regulatory switch for stimulus‐dependent E‐cadherin downregulation
por: Otake, Shigeo, et al.
Publicado: (2020)

Comparison of Snail1, ZEB1, E-Cadherin Expression Levels in HPV-Induced Cervical Cancer
por: FARZANEHPOUR, Mahdieh, et al.
Publicado: (2020)

Clinicopathologic Correlations of E-cadherin and Prrx-1 Expression Loss in Hepatocellular Carcinoma
por: Yi, Kijong, et al.
Publicado: (2016)

Ethnicity based variation in expression of E-cadherin in patients with squamous cell carcinoma of the oral tongue
por: Sgaramella, Nicola, et al.
Publicado: (2018)

Expression of miR-9 and miR-200c, ZEB1, ZEB2 and E-cadherin in Non-Small Cell Lung Cancers in Iran
por: Nourmohammadi, Bahareh, et al.
Publicado: (2019)

Prognostic impact of the loss of E-cadherin and de novo expression of N-cadherin at the invasive front of primary and recurrent oral squamous cell carcinoma
por: Hakim, Samer George, et al.
Publicado: (2023)

Expression of E-, P- and N-Cadherin and Its Clinical Significance in Cervical Squamous Cell Carcinoma and Precancerous Lesions
por: Li, Baohua, et al.
Publicado: (2016)

Comparison of p53, HSP90, E-cadherin and HPV in oral lichen planus and oral squamous cell carcinoma
por: Bar, Julia K., et al.
Publicado: (2021)

Significance of Worst Pattern of Invasion-5 in Early-Stage Oral Cavity Squamous Cell Carcinoma
por: Mohamed, Shima, et al.
Publicado: (2023)

Patients with advanced oral squamous cell carcinoma have high levels of soluble E-cadherin in the saliva
por: López-Verdín, Sandra, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ohgrpl8bl4v8qb8jbp30tvijeo